UCB appoints Steve Turley as managing director for British Isles and Ireland

Belgian pharma major UCB (Euronext: UCB) has appointed Steve Turley as managing director for the UK and Ireland.

He brings more than 20 years of commercial experience in biopharma, having worked across primary and specialty therapy areas at local and international levels. Mr Turley has worked at Merck (NYSE: MRK), Roche (SIX: ROG) and joins UCB from Lundbeck, where he was managing director for Lundbeck UK & Ireland.

Mr Turley said: “I am pleased to be joining a dynamic business that is focused on delivering medicines that really deliver for patients.  I am looking forward to building on that with our team here in the British Isles and Ireland.”